Third Arc Bio

Third Arc Bio is a biotechnology company developing multi-functional antibodies that can generate immune synapses for precise activation or inhibition of T cells. The company's drug development engine delivers superior biologics, optimized to create first-class T-cell engagement, leveraging two technologies to drive a pipeline of high-value therapies — the Solid Tumor Synergy Platform and the I&I Platform — offering a novel approach to precise immunomodulation at the tissue-specific level for superior efficacy and safety.